Consistently, tissue samples from 45 breast cancer patients had similar expression patterns, with ZEB2 and ACSL4 being relatively highly expressed in ER-negative patient samples (patients 6, 7, 8, and 9) (Figure 1—figure supplement 3A, B). This evidence concerns the gene ACSL4 and breast carcinoma.